View : 965 Download: 0
2-(Trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate promotes megakaryocytic differentiation of myeloid leukaemia cells and primary human CD34 + haematopoietic stem cells
- Title
- 2-(Trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate promotes megakaryocytic differentiation of myeloid leukaemia cells and primary human CD34 + haematopoietic stem cells
- Authors
- Limb J.-K.; Song D.; Jeon M.; Han S.-Y.; Han G.; Jhon G.-J.; Bae Y.S.; Kim J.
- Ewha Authors
- 전길자; 배윤수; 한소엽; 김재상; 임진경
- SCOPUS Author ID
- 전길자; 배윤수; 한소엽; 김재상; 임진경
- Issue Date
- 2012
- Journal Title
- Journal of Tissue Engineering and Regenerative Medicine
- ISSN
- 1932-6254
- Citation
- Journal of Tissue Engineering and Regenerative Medicine
- Indexed
- SCIE; SCOPUS
- Document Type
- Article in Press
- Abstract
- In this study we showed that 2-(trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate [(R)-TEMOSPho], a derivative of an organic chemical identified from a natural product library, promotes highly efficient differentiation of megakaryocytes. Specifically, (R)-TEMOSPho induces cell cycle arrest, cell size increase and polyploidization from K562 and HEL cells, which are used extensively to model megakaryocytic differentiation. In addition, megakaryocyte-specific cell surface markers showed a dramatic increase in expression in response to (R)-TEMOSPho treatment. Importantly, we demonstrated that such megakaryocytic differentiation can also be induced from primary human CD34 + haematopoietic stem cells. Activation of the PI3K-AKT pathway and, to a lesser extent, the MEK-ERK pathway appears to be required for this process, as blocking with specific inhibitors interferes with the differentiation of K562 cells. A subset of (R)-TEMOSPho-treated K562 cells undergoes spontaneous apoptosis and produces platelets that are apparently functional, as they bind to fibrinogen, express P-selectin and aggregate in response to SFLLRN and AYPGFK, the activating peptides for the PAR1 and PAR4 receptors, respectively. Taken together, these results indicate that (R)-TEMOSPho will be useful for dissecting the molecular mechanisms of megakaryocytic differentiation, and that this class of compounds represents potential therapeutic reagents for thrombocytopenia. © 2012 John Wiley & Sons, Ltd.
- DOI
- 10.1002/term.1628
- Appears in Collections:
- 자연과학대학 > 화학·나노과학전공 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML